Following his not too surprising nomination of Tom Price for the head of HHS, he now turns his attention to another big player, the Food and Drug Administration. While the FDA plays a major role in the safety of food products in the United States, not much is said about that during political campaigns or in decision making. It's role in pharma, medical devices, and now mobile health applications draws headlines.
What most industry reporters usually mention is the length of time and the expense of developing new drugs, and how that contributes to increased drug costs.
President Trump has repeatedly said that the FDA needs to be overhauled. He’s talked about speeding up drug approvals and reducing regulations — he’s vetted possible FDA heads who want to put drugs to market before we know they are effective. But, outside the White House and Capitol Hill, is there anyone who agrees with this? STAT’s Damian Garde takes a look.
Trump has big plans to fix drug prices. Here’s your reality check
Eli Lilly has raised the price of insulin more than tenfold since 2001 and is now facing a class-action lawsuit and threats of a congressional investigation.